tetraethylammonium has been researched along with ramipril in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Runnells, AM; Rusch, NJ | 1 |
Cox, RH; Dietz, NJ; Lozinskaya, I; Matsuda, K | 1 |
2 other study(ies) available for tetraethylammonium and ramipril
Article | Year |
---|---|
Remission of high blood pressure reverses arterial potassium channel alterations.
Topics: Animals; Aorta; Blood Pressure; Electrophysiology; Hypertension; Muscle, Smooth, Vascular; Potassium Channel Blockers; Potassium Channels; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetraethylammonium; Tetraethylammonium Compounds | 1994 |
Ramipril treatment alters Ca(2+) and K(+) channels in small mesenteric arteries from Wistar-Kyoto and spontaneously hypertensive rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Antihypertensive Agents; Calcium Channel Agonists; Calcium Channels, L-Type; Male; Membrane Potentials; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Potassium Channel Blockers; Potassium Channels; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetraethylammonium | 2002 |